Cicero Diagnostics is a women’s healthcare diagnostics company. It is dedicated to the advancement of clinical assays for understudied women’s diseases primarily in the area of infertility. Its current testing platforms, under the brand ReceptivaDx, include several biomarkers highly associated with inflammation on the uterine lining most often diagnosed as endometriosis.